This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
fin-tech: Archive
MetLife Teams Up With Sprout.ai to Advance Global Claims Automation
by Zacks Equity Research
MET taps Sprout.ai to speed up global claims processing, blending AI automation with human-centered service.
METNegative Net Change HRTGNegative Net Change PGYNegative Net Change AAMIPositive Net Change
artificial-intelligence fin-tech finance insurance
Marsh & McLennan to Acquire Validate Health to Expand Healthcare Reach
by Zacks Equity Research
MMC's Oliver Wyman to acquire Validate Health, boosting analytics capabilities for value-based healthcare growth.
MMCNegative Net Change HRTGNegative Net Change PGYNegative Net Change AAMIPositive Net Change
artificial-intelligence fin-tech finance insurance
Robinhood Hits All-Time High: Is it Too Late to Buy HOOD Stock?
by Swayta Shah
HOOD hits a record high of $85.55, backed by global expansion, crypto bets and bold diversification moves. Is there still room to run? Let's have a closer look.
SCHWPositive Net Change IBKRPositive Net Change HOODPositive Net Change
banking fin-tech finance
Will Affirm's Auto Move With Shopmonkey Fuel More Repeat Users?
by Kaibalya Pravo Dey
AFRM partners with Shopmonkey to bring pay-over-time options to auto repairs, targeting repeat users and steady spending.
PYPLPositive Net Change AFRMPositive Net Change XYZPositive Net Change
fin-tech finance payments
Zacks Investment Ideas feature highlights: Coinbase, Circle Internet, Visa, American Express and Shopify
by Zacks Equity Research
COIN hits a new 52-week high as stablecoin growth, regulatory wins, and analyst upgrades drive bullish momentum.
VNegative Net Change AXPPositive Net Change SHOPPositive Net Change COINPositive Net Change CRCLNegative Net Change
fin-tech
SoFi's Valuation Looks Overstretched: Time to Hit Pause?
by Zacks Equity Research
SOFI's 21% rally reflects investor optimism, but with a 41X P/E, some are questioning if the stock's run is overdone.
UPSTPositive Net Change SOFIPositive Net Change XYZPositive Net Change
fin-tech finance
Mastercard Expands Digital Currency Reach via Fiserv & Chainlink
by Zacks Equity Research
MA teams with Fiserv and Chainlink to expand stablecoin access and power on-chain crypto purchases for billions.
MANegative Net Change GDOTPositive Net Change OPFIPositive Net Change SEZLPositive Net Change
bitcoin blockchain cryptocurrency fin-tech finance payments
Synchrony Partners With Sploot to Make Pet Healthcare More Affordable
by Zacks Equity Research
SYF teams up with Sploot to launch CareCredit at pet clinics, expanding access to veterinary financing in key cities.
SYFPositive Net Change HRTGNegative Net Change PGYNegative Net Change AAMIPositive Net Change
fin-tech finance payments
Peakstone Realty Trust (PKST) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
PKSTNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
STMicroelectronics (STM)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
STMPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy ASML (ASML) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
ASMLPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Can Strategic Funding Deals Keep Affirm Ahead in the BNPL Space?
by Kaibalya Pravo Dey
AFRM extends its key funding deal with MSC through 2027, reinforcing growth and stability in the BNPL market.
PYPLPositive Net Change AFRMPositive Net Change XYZPositive Net Change
fin-tech finance payments
The Zacks Analyst Blog Highlights CME, Accenture, Visa and PayPal
by Zacks Equity Research
As Bitcoin rebounds, CME, ACN, V and PYPL gain traction with crypto offerings and rising earnings projections.
CMEPositive Net Change ACNNegative Net Change VNegative Net Change PYPLPositive Net Change
fin-tech
STNE vs. PYPL: Why StoneCo Offers More Upside Than PayPal Currently
by Urmimala Biswas
STNE is outpacing PYPL with strong buybacks, local innovation and greater valuation upside potential.
PYPLPositive Net Change STNENegative Net Change
cloud-computing fin-tech tech-stocks
Aon Unveils AI-Powered Broker Copilot to Modernize Insurance Placement
by Zacks Equity Research
AON launches AI-powered Broker Copilot to streamline insurance placement and sharpen broker decision-making.
AONNegative Net Change EVERNegative Net Change HMNNegative Net Change HRTGNegative Net Change
fin-tech finance insurance
Euroseas Ltd. (ESEA) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
ESEAPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Zacks Investment Ideas feature highlights: Priority Technology and OppFi
by Zacks Equity Research
PRTH and OPFI are two under $20 fintech stocks with strong earnings growth and major upside potential in 2025 and beyond.
PRTHPositive Net Change OPFIPositive Net Change
fin-tech
Visa's Crypto Integration: A Game Changer or a Risky Bet?
by Zacks Equity Research
V taps into stablecoins and tokenized assets as it deepens crypto ties. However, regulatory risks still remain.
MANegative Net Change VNegative Net Change PYPLPositive Net Change
blockchain business-services cryptocurrency fin-tech finance
Sea Eyes Fintech Growth: Is Monee the Next Revenue Pillar?
by Zacks Equity Research
Monee outpaces SE's core Shopee and Garena with 57.6% revenue growth in first-quarter 2025, fueled by lending scale and new market traction.
SENegative Net Change PYPLPositive Net Change GRABNegative Net Change
fin-tech tech-stocks
Qiagen (QGEN) Just Flashed Golden Cross Signal: Do You Buy?
by Zacks Equity Research
Good things could be on the horizon when a stock experiences a golden cross event. How should investors react?
QGENPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
2 Top-Ranked Cheap Stocks to Buy Now for Huge Upside
by Benjamin Rains
Dive into cheap, tech-focused Zacks Rank #1 (Strong Buy) stocks trading for well under $20 a share that offer long-term upside in July and beyond.
PRTHPositive Net Change OPFIPositive Net Change
fin-tech tech-stocks
After Golden Cross, Agenus (AGEN)'s Technical Outlook is Bright
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AGENPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Sportsman's Warehouse (SPWH)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
SPWHPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
SYF Joins Forces With Payzer to Streamline Home Improvement Financing
by Zacks Equity Research
Synchrony teams up with Payzer to embed financing into contractor tools, aiming to boost speed, flexibility and customer satisfaction.
SYFPositive Net Change HRTGNegative Net Change VIRTPositive Net Change PGYNegative Net Change
construction fin-tech finance
Will PGIM's $3B Facility Help Affirm Scale its BNPL Offerings Fast?
by Kaibalya Pravo Dey
AFRM's pass-through loan facility from PGIM can boost its BNPL growth while reducing funding risks and costs.
PRUNegative Net Change PYPLPositive Net Change AFRMPositive Net Change XYZPositive Net Change
fin-tech finance payments